 Receptor Protein-Tyrosine Kinases
"Receptor Protein-Tyrosine Kinases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of cellular receptors that have an intrinsic PROTEIN-TYROSINE KINASE activity.
| Descriptor ID |
D020794
|
| MeSH Number(s) |
D08.811.913.696.620.682.725.400 D12.776.543.750.630
|
| Concept/Terms |
Receptor Protein-Tyrosine Kinases- Receptor Protein-Tyrosine Kinases
- Kinases, Receptor Protein-Tyrosine
- Protein-Tyrosine Kinases, Receptor
- Receptor Protein Tyrosine Kinases
- Receptors, Protein-Tyrosine Kinase
- Protein-Tyrosine Kinase Receptors
- Receptors, Protein Tyrosine Kinase
- PTK Receptors
- Receptors, PTK
- Tyrosine Kinase Receptors
- Protein-Tyrosine Kinase Receptor
- Receptor, Protein-Tyrosine Kinase
- Receptor Protein-Tyrosine Kinase
- Kinase, Receptor Protein-Tyrosine
- Protein-Tyrosine Kinase, Receptor
- Receptor Protein Tyrosine Kinase
- Tyrosine Kinase Linked Receptors
|
Below are MeSH descriptors whose meaning is more general than "Receptor Protein-Tyrosine Kinases".
Below are MeSH descriptors whose meaning is more specific than "Receptor Protein-Tyrosine Kinases".
- Receptor Protein-Tyrosine Kinases
- c-Mer Tyrosine Kinase
- Discoidin Domain Receptors
- ErbB Receptors
- fms-Like Tyrosine Kinase 3
- Proto-Oncogene Proteins c-kit
- Proto-Oncogene Proteins c-met
- Proto-Oncogene Proteins c-ret
- Receptor Tyrosine Kinase-like Orphan Receptors
- Receptor, Fibroblast Growth Factor, Type 1
- Receptor, Fibroblast Growth Factor, Type 2
- Receptor, Fibroblast Growth Factor, Type 3
- Receptor, Fibroblast Growth Factor, Type 4
- Receptor, IGF Type 1
- Receptor, Insulin
- Receptor, Macrophage Colony-Stimulating Factor
- Receptor, trkA
- Receptor, trkB
- Receptor, trkC
- Receptors, Eph Family
- Receptors, Platelet-Derived Growth Factor
- Receptors, TIE
- Receptors, Vascular Endothelial Growth Factor
This graph shows the total number of publications written about "Receptor Protein-Tyrosine Kinases" by people in this website by year, and whether "Receptor Protein-Tyrosine Kinases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 1 | 2 | | 1995 | 1 | 0 | 1 | | 1996 | 1 | 2 | 3 | | 1997 | 0 | 2 | 2 | | 1998 | 1 | 1 | 2 | | 1999 | 1 | 2 | 3 | | 2000 | 3 | 1 | 4 | | 2001 | 1 | 2 | 3 | | 2002 | 5 | 1 | 6 | | 2003 | 2 | 1 | 3 | | 2004 | 0 | 3 | 3 | | 2006 | 4 | 1 | 5 | | 2007 | 1 | 0 | 1 | | 2008 | 2 | 1 | 3 | | 2009 | 2 | 1 | 3 | | 2010 | 3 | 2 | 5 | | 2011 | 6 | 0 | 6 | | 2012 | 10 | 1 | 11 | | 2013 | 13 | 8 | 21 | | 2014 | 7 | 2 | 9 | | 2015 | 11 | 5 | 16 | | 2016 | 8 | 1 | 9 | | 2017 | 5 | 4 | 9 | | 2018 | 6 | 1 | 7 | | 2019 | 2 | 4 | 6 | | 2020 | 0 | 3 | 3 | | 2021 | 2 | 5 | 7 | | 2022 | 0 | 6 | 6 | | 2023 | 0 | 2 | 2 | | 2024 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptor Protein-Tyrosine Kinases" by people in Profiles.
-
Smith MD, Wilkins KD, Holdrege MC, Wilfahrt P, Collins SL, Knapp AK, Sala OE, Dukes JS, Phillips RP, Yahdjian L, Gherardi LA, Ohlert T, Beier C, Fraser LH, Jentsch A, Loik ME, Maestre FT, Power SA, Yu Q, Felton AJ, Munson SM, Luo Y, Abdoli H, Abedi M, Alados CL, Alberti J, Alon M, An H, Anacker B, Anderson M, Auge H, Bachle S, Bahalkeh K, Bahn M, Batbaatar A, Bauerle T, Beard KH, Behn K, Beil I, Biancari L, Blindow I, Bondaruk VF, Borer ET, Bork EW, Bruschetti CM, Byrne KM, Cahill JF, Calvo DA, Carbognani M, Cardoni A, Carlyle CN, Castillo-Garcia M, Chang SX, Chieppa J, Cianciaruso MV, Cohen O, Cordeiro AL, Cusack DF, Dahlke S, Daleo P, D'Antonio CM, Dietterich LH, S Doherty T, Dubbert M, Ebeling A, Eisenhauer N, Fischer FM, Forte TGW, Gebauer T, Gozalo B, Greenville AC, Guidoni-Martins KG, Hannusch HJ, Vats? Haugum S, Hautier Y, Hefting M, Henry HAL, Hoss D, Ingrisch J, Iribarne O, Isbell F, Johnson Y, Jordan S, Kelly EF, Kimmel K, Kreyling J, Kr?el-Dulay G, Kr?pfl A, K?bert A, Kulmatiski A, Lamb EG, Larsen KS, Larson J, Lawson J, Leder CV, Linst?dter A, Liu J, Liu S, Lodge AG, Longo G, Loydi A, Luan J, Curtis Lubbe F, Macfarlane C, Mackie-Haas K, Malyshev AV, Maturano-Ruiz A, Merchant T, Metcalfe DB, Mori AS, Mudongo E, Newman GS, Nielsen UN, Nimmo D, Niu Y, Nobre P, O'Connor RC, Ogaya R, O?atibia GR, Orb?n I, Osborne B, Otfinowski R, P?rtel M, Penuelas J, Peri PL, Peter G, Petraglia A, Picon-Cochard C, Pillar VD, Pi?eiro-Guerra JM, Ploughe LW, Plowes RM, Portales-Reyes C, Prober SM, Pueyo Y, Reed SC, Ritchie EG, Rodr?guez DA, Rogers WE, Roscher C, S?nchez AM, Santos BA, Cecilia Scarf? M, Seabloom EW, Shi B, Souza L, Stampfli A, Standish RJ, Sternberg M, Sun W, S?nnemann M, Tedder M, Thorvaldsen P, Tian D, Tielb?rger K, Valdecantos A, van den Brink L, Vandvik V, Vankoughnett MR, Guri Velle L, Wang C, Wang Y, Wardle GM, Werner C, Wei C, Wiehl G, Williams JL, Wolf AA, Zeiter M, Zhang F, Zhu J, Zong N, Zuo X. Extreme drought impacts have been underestimated in grasslands and shrublands globally. Proc Natl Acad Sci U S A. 2024 Jan 23; 121(4):e2309881120.
-
Gestrich CK, Davis JL, Biederman L, John I, Alaggio R, Giovannoni I, Arnold MA, Shenoy A, Tchakarov A, Al-Ibraheemi A. ALK-Rearranged Epithelioid Mesenchymal Neoplasm: Expanding the Spectrum of Tyrosine Kinase-Altered Mesenchymal Tumors. Mod Pathol. 2023 Dec; 36(12):100334.
-
Gilani A, Siddiq Z, Kissell E, Kasson J, Kleinschmidt-DeMasters BK. Genomic and epigenomic re-categorization of congenital glioblastoma and desmoplastic infantile ganglioglioma. Childs Nerv Syst. 2023 07; 39(7):1861-1868.
-
Wandrey NE, Gao D, Robin TP, Contessa JN, Singh C, Chiang V, Li J, Chen A, Wang Y, Sheehan JP, Dutta SW, Weiss SE, Paly J, Rusthoven CG. Multicenter analysis of stereotactic radiosurgery for multiple brain metastases from EGFR and ALK driven non-small cell lung cancer. Lung Cancer. 2023 02; 176:144-148.
-
Rusch VW, Nicholas A, Patterson GA, Waqar SN, Toloza EM, Haura EB, Raz DJ, Reckamp KL, Merritt RE, Owen DH, Finley DJ, McNamee CJ, Blasberg JD, Garon EB, Mitchell JD, Doebele RC, Baciewicz F, Nagasaka M, Pass HI, Schulze K, Johnson A, Bunn PA, Johnson BE, Kris MG, Kwiatkowski DJ, Wistuba II, Chaft JE, Carbone DP, Lee JM. Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2023 03; 165(3):828-839.e5.
-
Desai AV, Robinson GW, Gauvain K, Basu EM, Macy ME, Maese L, Whipple NS, Sabnis AJ, Foster JH, Shusterman S, Yoon J, Weiss BD, Abdelbaki MS, Armstrong AE, Cash T, Pratilas CA, Corradini N, Marshall LV, Farid-Kapadia M, Chohan S, Devlin C, Meneses-Lorente G, Cardenas A, Hutchinson KE, Bergthold G, Caron H, Chow Maneval E, Gajjar A, Fox E. Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG). Neuro Oncol. 2022 10 03; 24(10):1776-1789.
-
Chaft JE, Oezkan F, Kris MG, Bunn PA, Wistuba II, Kwiatkowski DJ, Owen DH, Tang Y, Johnson BE, Lee JM, Lozanski G, Pietrzak M, Seweryn M, Byun WY, Schulze K, Nicholas A, Johnson A, Grindheim J, Hilz S, Shames DS, Rivard C, Toloza E, Haura EB, McNamee CJ, Patterson GA, Waqar SN, Rusch VW, Carbone DP. Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial. Nat Med. 2022 10; 28(10):2155-2161.
-
Chakravarty D, Johnson A, Sklar J, Lindeman NI, Moore K, Ganesan S, Lovly CM, Perlmutter J, Gray SW, Hwang J, Lieu C, Andr? F, Azad N, Borad M, Tafe L, Messersmith H, Robson M, Meric-Bernstam F. Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion. J Clin Oncol. 2022 04 10; 40(11):1231-1258.
-
Thomas NJ, Myall NJ, Sun F, Patil T, Mushtaq R, Yu C, Sinha S, Pollom EL, Nagpal S, Camidge DR, Rusthoven CG, Braunstein SE, Wakelee HA, McCoach CE. In Response to: "Comparing Addition of Radiotherapy in EGFR- and ALK-Positive NSCLC With Brain Metastases: Are We Evaluating the Optimal Endpoint?" J Thorac Oncol. 2022 02; 17(2):e12-e14.
-
Tan DS, Thomas M, Kim DW, Szpakowski S, Urban P, Mehra R, Chow LQM, Sharma S, Solomon BJ, Felip E, Camidge DR, Vansteenkiste J, Petruzzelli L, Pantano S, Shaw AT. Genetic landscape of patients with ALK-rearranged non-small-cell lung cancer (NSCLC) and response to ceritinib in ASCEND-1 study. Lung Cancer. 2022 01; 163:7-13.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|